How Do Medical MLLMs Fail? A Study on Visual Grounding in Medical Images
Organizations: Singapore University of Technology and Design, Singapore · Department of Neurology, National Neuroscience Institute, Singapore · Duke-NUS Medical School, Singapore
Abstract
Generalist multimodal large language models (MLLMs) have achieved impressive performance across a wide range of vision-language tasks. However, their performance on medical tasks, particularly in zero-shot settings where generalization is critical, remains suboptimal. A key research gap is the limited understanding of why medical MLLMs underperform in medical image interpretation. In this work, we present a pioneering systematic investigation into the visual grounding capabilities of state-of-the-art medical MLLMs. To disentangle visual grounding from semantic grounding, we design VGMED, a novel evaluation dataset developed with expert clinical guidance, explicitly assessing the visual grounding capability of medical MLLMs. We introduce new quantitative metrics and conduct detailed qualitative analyses. Our study across eight state-of-the-art (SOTA) medical MLLMs validates that they often fail to ground their predictions in clinically relevant image regions. We note that this finding is specific to medical image analysis; in contrast, prior work has shown that MLLMs are capable of grounding their predictions in the correct image regions when applied to natural scene images. Motivated by these findings, we propose VGRefine, a simple yet effective inference-time method that refines attention distribution to improve visual grounding in medical settings. Our approach achieves SOTA performance across 6 diverse Med-VQA benchmarks (over 110K VQA samples from 8 imaging modalities) without requiring additional training or external expert models. Overall, our work, for the first time, systematically validates inadequate visual grounding as one of the key contributing factors for medical MLLMs' under-performance. Additional experiments are included in the Supp.
Figures & tables
| Model | VQA-RAD | SLAKE | PathVQA | PMC-VQA | Avg. |
| Qwen-VL-Chat | 47.0 | 56.0 | 55.1 | 36.6 | 48.9 |
| LLaVA-v1.6-7B | 52.6 | 57.9 | 47.9 | 35.5 | 48.5 |
| Med-Flamingo | 45.4 | 43.5 | 54.7 | 23.3 | 41.7 |
| RadFM | 50.6 | 34.6 | 38.7 | 25.9 | 37.5 |
| LLaVA-Med-7B | 51.4 | 48.6 | 56.8 | 24.7 | 45.4 |
| LLaVA-Tri | 59.8 | 43.4 | 59.0 | - | - |
| Model | BMS | CM | DLM | P | PH | Avg. |
| Qwen-VL-Chat | 36.5 | 31.7 | 32.7 | 28.4 | 34.6 | 32.7 |
| LLaVA-v1.6-7B | 40.5 | 36.9 | 32.1 | 32.3 | 26.9 | 33.1 |
| Med-Flamingo | 29.6 | 28.1 | 24.8 | 25.3 | 31.2 | 28.3 |
| RadFM | 27.5 | 26.8 | 25.8 | 24.7 | 29.1 | 27.0 |
| LLaVA-Med-7B | 39.9 | 39.1 | 34.6 | 37.4 | 34.0 | 36.9 |
| LLaVA-Tri | 37.1 | - | 27.8 | - | - | - |
| Model | CT | FP | MRI | OCT | Der | Mic | X-Ray | US | Avg. |
| Qwen-VL-Chat ( Bai et al., 2023 ) | 51.5 | 45.4 | 43.9 | 54.0 | 55.4 | 49.5 | 63.1 | 33.5 | 49.5 |
| LLaVA-v1.6-7B ( Liu et al., 2024a ) | 40.1 | 39.5 | 54.8 | 58.4 | 54.0 | 48.8 | 53.3 | 47.9 | 49.6 |
| Med-Flamingo ( Moor et al., 2023 ) | 34.6 | 33.3 | 27.5 | 26.0 | 28.3 | 28.1 | 30.1 | 33.2 | 30.2 |
| RadFM ( Wu et al., 2023 ) | 33.3 | 35.0 | 22.0 | 31.3 | 36.3 | 28.0 | 31.5 | 26.1 | 30.5 |
| LLaVA-Med-7B ( Li et al., 2023a ) | 25.3 | 48.4 | 35.9 | 42.1 | 45.2 | 44.0 | 31.7 | 34.4 | 35.8 |
| VILA-M3-8B ( Nath et al., 2024 ) | 60.2 | 35.7 | 51.5 | 56.9 | 51.5 | 51.7 | 65.4 | 46.1 | 53.0 |
| VQA-RAD | SLAKE | PathVQA | PMC-VQA | Avg. | (%) | VQA-RAD | SLAKE | PathVQA | PMC-VQA | Avg. | |
| 1 | 68.62 | 75.81 | 64.85 | 53.65 | 68.28 | 30 | 70.78 | 76.84 | 67.55 | 55.70 | 68.22 |
| 2 | 69.78 | 76.63 | 63.58 | 53.90 | 68.21 | 40 | 70.70 | 76.66 | 67.28 | 56.00 | 68.12 |
| 5 | 70.09 | 76.56 | 66.52 | 54.30 | 68.08 | 50 | 71.24 | 76.88 | 67.61 | 56.20 | 68.42 |
| 8 | 70.70 | 76.52 | 66.64 | 55.60 | 68.12 | 60 | 70.70 | 76.66 | 67.28 | 55.65 | 68.05 |
| 10 | 70.86 | 76.81 | 67.67 | 56.05 | 68.34 | 70 | 70.47 | 76.66 | 67.61 | 55.80 | 68.17 |
| 15 | 70.78 | 76.84 | 67.43 | 55.40 | 68.11 | 80 | 70.78 | 76.73 | 67.55 | 55.80 | 68.21 |
Appendix figures & tables34 assets
Supplementary material from the paper’s appendix.
Appendix
| Related works | No. of Samples | Data Source |
| MLLMs Know ( Zhang et al., 2025a ) | 4,370 | Text-VQA |
| Your LVLM ( Kang et al., 2025 ) | 1,000 | RefCOCO |
| What’s in the Image ( Kaduri et al., 2024 ) | 81 | COCO |
| Hallucination Attribution ( Yang et al., 2025 ) | 1,500 | COCO |
| Devils in LVLM ( Jiang et al., 2025 ) | 2,000 | COCO |
| FastV ( Chen et al., 2025a ) | 1,000 | 4 VL Tasks |
| Dataset | Modality | Anatomical Structures |
| AMOS2022 ( Ji et al., 2022 ) | CT, MR | Abdomen, Thorax, Pelvic |
| ATM2022 ( Zhang et al., 2023a ) | CT | Thorax |
| AbdomenomenCT-1K ( Ma et al., 2022b ) | CT | Abdomen |
| BTCV ( Igelsias et al., 2015 ) | CT | Thorax, Abdomen, Pelvic |
| BraTS2013 ( Menze et al., 2015 ) | MR | Head & neck |
| BraTS2015 ( Menze et al., 2015 ) | MR | Head & neck |
| Model | VQA-RAD | SLAKE | PathVQA | |||||||||
| Metric | BLEU-1 | BERT | OpenRecall | Avg. | BLEU-1 | BERT | OpenRecall | Avg. | BLEU-1 | BERT | OpenRecall | Avg. |
| Qwen-VL-Chat | 28.6 | 63.4 | 27.0 | 39.7 | 28.9 | 52.0 | 33.6 | 38.2 | 18.7 | 45.1 | 9.9 | 24.6 |
| LLaVA-v1.6-7B | 22.1 | 58.0 | 21.9 | 34.0 | 30.8 | 52.7 | 36.4 | 40.0 | 22.8 | 47.7 | 11.2 | 27.2 |
| Med-Flamingo | 27.4 | 61.9 | 12.7 | 34.0 | 11.8 | 40.2 | 21.1 | 24.4 | 24.3 | 50.4 | 2.4 | 25.7 |
| RadFM | 30.5 | 64.1 | 41.6 | 45.4 | 38.6 | 61.0 | 44.2 | 47.9 | 24.8 | 51.4 | 10.1 | 29.8 |
| LLaVA-Med-7B | 21.6 | 40.5 | 28.2 | 30.1 | 37.0 | 58.4 | 39.2 | 44.9 | 28.5 | 60.1 | 12.3 | 33.6 |
| Model | VQA-RAD | SLAKE | PathVQA | PMC-VQA | Avg. |
| HuatuoGPT-V-7B (Baseline) | 67.4 | 76.5 | 60.7 | 53.9 | 65.3 |
| PAI ( Liu et al., 2024c ) | 43.7 | 24.48 | 20.8 | 52.8 | 33.3 |
| AdaptVis ( Chen et al., 2025b ) | 68.6 | 75.1 | 67.6 | 52.9 | 66.7 |
| ViCrop ( Zhang et al., 2025a ) | 68.9 | 70.9 | 66.7 | 54.6 | 65.5 |
| VGRefine (Ours) | 71.2 | 76.9 | 67.6 | 56.2 | 68.4 |
| Benchmarks | Subset | Metric | LLaVA-v1.6-34B | VILA-M3-13B | MedRegA-34B | HuatuoGPT-V-34B | VGRefine-34B (Ours) |
| VQA-RAD | - | CloseAcc | 58.6 | - | - | 68.1 | 72.9 |
| BLEU-1 | 44.5 | - | - | 50.5 | 52.6 | ||
| BERT | 69.2 | - | - | 74.8 | 74.8 | ||
| OpenRecall | 43.6 | - | - | 51.7 | 52.8 | ||
| SLAKE | - | CloseAcc | 67.3 | - | - | 76.9 | 79.1 |
| BLEU-1 | 48.6 | - | - | 56.3 | 57.2 |
| Type | Category | Rating 3 (%) | Rating 4 (%) | Rating 5 (%) |
| Attribute | Clinical Relevance | 3.31 | 4.11 | 92.58 |
| Min. Semantic Grounding | 0.37 | 10.38 | 89.25 | |
| Visual Grounding | 4.04 | 12.18 | 83.77 | |
| Localization | Clinical Relevance | 0.02 | 0.52 | 99.46 |
| Min. Semantic Grounding | 0.05 | 5.76 | 94.19 | |
| Visual Grounding | 3.96 | 11.79 | 84.25 |